VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
WOOF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
WOOFPetco Health and Wellness Company, Inc.
$2.96$845M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksWOOFBalance Sheet

Petco Health and Wellness Company, Inc. (WOOF) Balance Sheet

8Y historyFree accessUpdated daily

The company has aggressively reduced total debt from $4.0 billion to $1.5 billion, improving the debt-to-equity ratio to 1.22, but this deleveraging has occurred against a backdrop of stagnant equity and deeply negative retained earnings of -$1.1 billion.

Income StatementBalance SheetCash FlowRatios

WOOF Balance Sheet

Annual statement

WOOF Balance Sheet

Petco Health and Wellness Company, Inc. (WOOF) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMJan'26Feb'25Feb'24Jan'23Jan'22Jan'21Feb'20Feb'19
Total Current Assets1.05B1.02B973.62M951.74M1.02B1.07B777.55M711M761.61M
Cash & Short-Term Investments293.5M256.74M165.76M125.43M201.9M211.6M111.4M148.78M180.65M
Cash Only293.5M256.74M165.76M125.43M201.9M211.6M111.4M148.78M180.65M
Short-Term Investments000000000
Accounts Receivable38.39M45.81M40.42M44.37M49.58M55.62M41.83M31.52M27.88M
Days Sales Outstanding2.512.82.412.5933.53.12.592.32
Inventory601.59M590.21M653.33M684.5M652.43M675.11M538.67M478.97M470.14M
Days Inventory Outstanding61.0658.9262.8964.0465.9972.8969.8869.1568.99
Other Current Assets65.19M75.28M60.59M38.83M60.81M86.09M45.61M26.88M34.17M
Total Non-Current Assets4.11B4.15B4.22B4.41B5.6B5.43B5.3B5.45B4.16B
Property, Plant & Equipment1.9B1.94B2.03B2.2B2.2B2.07B1.96B2.12B683.55M
Fixed Asset Turnover2.54x3.07x3.02x2.84x2.74x2.81x2.52x2.10x6.43x
Goodwill980.06M980.06M980.06M980.3M2.19B2.18B2.18B2.18B2.18B
Intangible Assets1.02B1.02B1.02B1.02B1.02B1.02B1.02B1.03B1.17B
Long-Term Investments0013.95M000000
Other Non-Current Assets209.67M203.83M174.02M205.69M176.81M152.79M138.19M122.39M130.93M
Total Assets5.17B5.17B5.19B5.36B6.61B6.5B6.08B6.16B4.92B
Asset Turnover1.16x1.15x1.18x1.17x0.91x0.89x0.81x0.72x0.89x
Asset Growth %-0.98%-0.4%-3.15%-18.9%1.77%6.95%-1.29%24.99%-
Total Current Liabilities1.17B1.13B1.14B1.11B1.02B1.05B875.31M841.94M543.47M
Accounts Payable455.31M450.55M492.88M485.13M381.21M403.98M339.49M293.2M276.93M
Days Payables Outstanding45.4144.9847.4445.3938.5643.6244.0442.3340.64
Short-Term Debt12.06M324.69M23.31M15.96M22.79M21.76M2.2M28.64M28.35M
Deferred Revenue (Current)0029.56M33.52M23.05M18M15.53M00
Other Current Liabilities340.64M358.9M134.15M85.3M89.93M150.63M129.48M93.69M94.27M
Current Ratio0.90x0.90x0.85x0.86x0.99x1.02x0.89x0.84x1.40x
Quick Ratio0.39x0.38x0.28x0.24x0.36x0.38x0.27x0.28x0.54x
Cash Conversion Cycle18.1616.7517.8621.2430.4332.7728.9429.4230.67
Total Non-Current Liabilities2.79B2.88B2.94B3.07B3.21B3.19B3.15B4.75B3.74B
Long-Term Debt1.46B1.49B1.58B1.58B1.63B1.64B1.65B3.23B3.2B
Capital Lease Obligations3.08B1.05B1.05B1.12B1.17B1.12B1.1B1.16B0
Deferred Tax Liabilities937.62M234.91M217.71M251.63M303.12M318.36M280.92M265.28M304.2M
Other Non-Current Liabilities1.08B104.41M100.18M112.9M106.84M109.05M122.92M101.65M241.38M
Total Liabilities3.96B4.01B4.08B4.18B4.23B4.24B4.02B5.59B4.29B
Total Debt1.48B2.86B2.96B3.04B3.13B3.05B3B4.69B3.23B
Net Debt1.18B2.6B2.79B2.92B2.93B2.84B2.89B4.54B3.05B
Debt / Equity1.22x2.46x2.66x2.57x1.32x1.35x1.46x8.36x5.06x
Debt / EBITDA4.46x9.02x14.31x-7.47x6.95x8.13x16.51x-
Net Debt / EBITDA3.57x8.21x13.51x-6.99x6.47x7.83x15.99x-
Interest Coverage1.13x1.12x0.11x-7.77x2.10x3.62x0.81x0.44x-0.88x
Total Equity1.21B1.16B1.11B1.18B2.38B2.26B2.06B561.06M637.91M
Equity Growth %17.93%4.55%-5.98%-50.26%5.57%9.76%266.32%-12.05%-
Book Value per Share4.154.074.074.438.958.509.760.380.44
Total Shareholders' Equity1.21B1.16B1.11B1.18B2.38B2.27B2.07B569.39M637.91M
Common Stock286K282K277K269K266K265K264K1.36B1.35B
Retained Earnings-1.12B-1.14B-1.15B-1.05B232.97M142.17M-22.25M-780.47M-707.52M
Treasury Stock000000000
Accumulated OCI-5.05M-8.39M-18.08M1.82M-4.1M-2.24M-1.27M-8.27M-2.19M
Minority Interest00000-18.2M-13.58M-8.33M0

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Leverage constrains strategic pivot

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Reduction Amidst Stagnant Equity

Petco's balance sheet has shown a notable deleveraging trend, with the debt-to-equity ratio falling from 3.46 in 2025Q3 to 1.22 in 2026Q2, yet this appears driven by debt repayment rather than equity growth, as total equity has remained flat at approximately $1.2 billion.

The sharp reduction in total debt from $4.0 billion to $1.5 billion over three quarters suggests a concerted effort to improve financial flexibility, likely using operating cash flow. However, the lack of corresponding equity growth, with retained earnings deeply negative at -$1.1 billion, indicates this deleveraging is not being funded by profitability but by asset reduction or cash generation, which may limit future investment capacity.

Significant Debt Reduction Improves Profile

Total debt has been aggressively reduced from $4.0 billion in 2025Q3 to $1.5 billion in 2026Q2, a 62.5% decrease that has materially improved the debt-to-equity ratio from 3.46 to 1.22, though the company remains significantly leveraged relative to its equity base.

This rapid deleveraging appears to be a strategic priority, likely aimed at reducing interest expense and refinancing risk in a high-rate environment. The current D/E of 1.22, while improved, still represents a substantial debt burden that may constrain strategic flexibility and limit capital allocation to growth initiatives like the veterinary clinic expansion.

Cash Position Volatile but Improving

Cash on hand has shown significant volatility, ranging from $89.7 million in 2024Q1 to $293.5 million in 2026Q2, while the current ratio has improved from 0.84 to 0.90, suggesting a modest strengthening in short-term liquidity but remaining below the 1.0 threshold that typically indicates full coverage of current liabilities.

The improvement in the current ratio, coupled with the recent cash buildup, suggests better working capital management or debt repayment timing. However, the ratio remaining below 1.0 indicates that current liabilities still exceed current assets, which could pose a liquidity risk if operational cash flow weakens or if there is a sudden need for working capital.

Asset Base Stable with Significant Goodwill

Total assets have remained stable at approximately $5.2 billion, with goodwill constituting a substantial $980.1 million (18.8% of total assets) and property, plant, and equipment net of $1.9 billion, indicating a capital-intensive model with significant intangible value from past acquisitions.

The large goodwill balance represents a potential impairment risk if the company's market position or profitability deteriorates further, as it reflects the premium paid for past acquisitions. The significant PPE base aligns with the company's physical retail and veterinary clinic footprint, confirming the asset-heavy nature of its integrated service model.

Negative Retained Earnings Undermine Equity Quality

Equity quality is significantly impaired by accumulated retained earnings of negative $1.1 billion as of 2026Q2, indicating that historical losses have eroded the company's book value and that current profitability is insufficient to rebuild shareholder equity.

The persistent negative retained earnings suggest that the company has been unable to generate cumulative profits since its formation or since a major recapitalization event. This structural weakness means that the equity base provides a limited cushion against further losses and may restrict the company's ability to return capital to shareholders or fund growth internally.

Debt Reduction May Mask Underlying Weakness

The dramatic reduction in total debt from $4.0 billion to $1.5 billion may be masking underlying operational weakness, as the company's equity base has not grown and retained earnings remain deeply negative, suggesting the deleveraging is achieved through cash generation rather than profitable growth.

While the improved leverage metrics are positive, the source of the cash for debt repayment warrants scrutiny. If the reduction is primarily from operating cash flow rather than asset sales or equity raises, it may indicate that the company is prioritizing balance sheet repair over investment in its growth initiatives, potentially sacrificing long-term competitiveness for short-term financial stability.

WOOF — Frequently Asked Questions

Quick answers to the most common questions about buying WOOF stock.

What are the total assets of Petco Health and Wellness Company, Inc. (WOOF)?

As of 2025, Petco Health and Wellness Company, Inc. (WOOF) had total assets of $5.17B including $1.02B in current assets.

How much debt does Petco Health and Wellness Company, Inc. (WOOF) have?

Petco Health and Wellness Company, Inc. (WOOF) carries total debt of $2.86B, offset by $256.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Petco Health and Wellness Company, Inc.?

Petco Health and Wellness Company, Inc. (WOOF) has total shareholders' equity (book value) of $1.16B ($4.07 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Petco Health and Wellness Company, Inc.'s current ratio and liquidity?

Petco Health and Wellness Company, Inc. (WOOF) reported a current ratio of 0.90x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.